مواقع التدريسيينجامعة الكوفة
0Publications
0Lectures

About

EDUCATION:
• B.Sc .degree in Pharmacy Sciences / College of Pharmacy, University of Kufa 2012.
• M.Sc . In Pharmacology and Toxicology/ from University of Babylon / Faculty of Medicine 2019.
Ph.D. /Pharmacology &Therapeutics/ Faculty of Medicine-Kufa University 2024
OCCUPATION :
• Demonstrator in the Department Pharmaceutics and Industrial pharmacy /Faculty of Pharmacy /University of KUFA 2014 - 2017
• Lecturer in the Department Pharmacology and Toxicology /Faculty of Pharmacy /University of KUFA 2019

Publications

5
2026

Comparative in vitro evaluation of marketed antacids and natural remedies in Iraq

AuthorsAli N. Wannas, Abulfadhel Jabber Neamah AL-Shaibani, Sarah K. Obayes, Osamah N. Wennas
JournalJournal of Chemistry Letters
Date2026-05-01
Abstract

Antacids are commonly used to treat hyperacidity. In addition, several herbal remedies are traditionally used by elderly populations to relieve digestive disorders. The aim of the present work was to make a comparative in vitro evaluation of the acid-neutralizing and buffering capacities of marketed antacids and natural remedies in Iraq. Four marketed antacids and four herbs as herbal tea were subjected to antacid tests. A preliminary antacid test (PAT) was performed to demonstrate them as antacids. Acid neutralizing capacity (ANC) test (using back titration method) and buffering capacity test were performed to evaluate the efficacy and quality of marketed antacids and natural remedies. All tests were performed according to the criteria of the United States Pharmacopoeia (USP). The results of the study revealed that all marketed antacids and natural remedies possess a pH value above 3.5 and demonstrated antacid activity in PAT. The ANC values of marketed antacids were higher than the accepted minimal limit required by USP, which is 5 milliequivalents per minimal labeled dose (5 mEq/MLD). The buffering capacities of marketed antacids were maintained from 25 min to 50 min. The ANC values of the natural herbs were below the accepted limit, and their buffering capacities were maintained from 20 min to 30 min.Although herbal preparations demonstrated some degree of acid-neutralizing activity, their efficacy was lower than that of marketed antacids and did not meet pharmacopeial standards. Therefore, herbal remedies may provide supportive relief but should not be considered a substitute for standardized antacid therapy.

2025

Assay the Cytotoxicity of Agents Targeting K-RAS Oncogene in Treatment Colorectal Cancer

AuthorsZahraa F. Fleih, Bashaer M. Muhammad­Baqir, Sarah K. Obayes, Rawaa H. Shareef
JournalSurgery, Gastroenterology and Oncology
Date2025-01-31
Abstract

Background: Cancer is considered as the second leading cause of death and the most popular kind of gastrointestinal cancer is colorectal cancer that resulted from genetic alterations progressed during a lifetime. In human cancer, the most frequently mutated oncogenes but have not produced to therapeutic attack are RAS genes (KRAS, NRAS and HRAS). Methotrexate is a cytotoxic chemotherapeutic agent, as it acts on cell cycle. Aims: This study aims to investigate the cytotoxicity effect MEX2R and MEX2O in human colorectal cells and to compare its action with MTX. MEX2R and MEX2O investigational agents as K-RAS oncogene blocker which inhibits the cell proliferation by targeting the cell cycle. Methods: LST 174 colorectal cell line was grown in RPMI- 1640 media supplement with 10% heat inactivated fetal bovine serum and antibiotic 100IUs/ml penicillin with 100 μg/ml streptomycin. The cells were incubated with agents and drugs for 24 hours. Cells were inoculated in 96-well microtiter plate (105 cells/well) for 48 hrs. The final concentration of the solvent never exceeded 0.1%. Triplicates were prepared for each individual dose. Color intensity was measured in an ELISA reader. The viability and inhibition % of cancer cell line after the spec- ified time were then detected and the concentration that inhibit 50% of cell viability (IC50) was fitted and calculated. Results: There was no significant increase (P> 0.05) in cell growth inhibition as compared with control group at conc. (0.5,1,5 μg/ml) of MEX2R, while there was a highly significant increase (P≤0.05) in inhibition of growth LST174 cells in conc. (25, 125,625 μg/ml). Additionally, the conc.of drug that needed to inhibit a biological process or response by 50% (IC50) is about 411 mg/ml . The result showed that MEX2O has significant difference (P≤0.05) in LST174 cells growth inhibition in all concentrations (0.5,1.5.25,125,625 & 1000 μg/ml) when compared with control(untreated) group. While, the concentration of drug that needed to inhibit a biological process or response by 50% (IC50) is about 317.69 mg/ml. Also, the result showed that MTX has significant increase (P≤0.05) in growth inhibition of LST174 cells in all concentrations (0.5,1,5,25,125,625,1000 μg/ml) when compared with control group. While, the results showed that the conc. of drug that needed to inhibit a biological process or response by 50% (IC50) is about 803.8 mg/ml. Conclusion: MEX2R and MEX2O might be have a greater value in the treatment of this type of cancer than MTX as they act on the cell cycle as the tested drugs MEX2R & MEX2O acted on the cell cycle by targeting one of the main troubles that interfere with treatment of colorectal cancer which is K-RAS gene mutation and inhibit the cell proliferation. Keywords: Colorectal cancer, MEX2R, MEX2O, MTX, K-RAS gene mutation

2022

The Effective Role of Targeted Therapy in Advanced Colorectal Cancer

AuthorsSarah K. Obayes, Ali N. Wannas, Rana A. Ghaleb
JournalAl Mustansiriyah Journal of Pharmaceutical Sciences
Abstract

Though chemotherapy is the major strategy to manage patients with advanced-stage colorectal cancer (CRC), the main challenge is the progression of CRC despite using combination of different chemotherapeutic agents. So, to overcome this challenge, a new class Of therapy was developed naming “Targeted-therapy”. This class of drugs aim to target specific overexpressed or aberrant enzyme, receptor, or gene that have critical role in the growth and survival of colorectal cancerous cells. So that, by using combination of traditional strategy (chemotherapy) and targeted-drug, this will lead to improve survival and prevent the progression of advanced CRC.

2021

ANTICANCER EFFECTS OF COMBINED PHOTOBIOMODULATION, CARBOPLATIN, CASSIA FISTULA SEEDS EXTRACT AND GOLD NANOPARTICLES (AUNPS) ON PROSTATE CANCER CELL LINE (PC3)

AuthorsRana A. Ghaleb, Sarah k. Obayes and Zena Hasan Sahib
JournalBiochem. Cell. Arch.
Abstract

Although, chemotherapy still the main mode for managing cancer but its usage is limited by resistance and adverse effects which are depend on the dose. Other modes or techniques such as LASER irradiation, anti-cancer plant or nanometals particles can be used to solve this problem. In this study, we use three different agents (carboplatin, cassia fistula seed extract, and gold nanoparticles) where the cytotoxicity of them was investigated on prostate cancer (PC3) cell line. The PC3 cells were exposed to six doses for each of carboplatin, cassia fistula fruits extract, and gold nanoparticles. Then for each agent, the dose that gave significant decrease in the viability percent was used in combination with a constant dose of He-Ne laser (635 nm). From the results, we found that the inhibition percent was increased by the combination therapy as compared to the monotherapy for each agent.Also, the highest inhibition percent was observed in the combination of gold nanoparticles and 191 J/cm2 laser. In a conclusion, LAESR is an amazing technique to increase the cytotoxicity of the classical and non-classical methods for treating cancer especially its use in combination with gold nano-particles in the photo-thermal technique.

2019

An in vitro Study for the Synergistic Cytotoxic Actions of Biological Therapy and Anticancer Chemotherapy

Authorsسارة خضير عبيس, حامد ناجي عبيد محمد عبد كاظم
JournalIndian Journal of Forensic Medicine & Toxicology
Abstract

This study aimed to investigate the increase of the cytotoxic action of a minimal dose of anticancer chemotherapy (temozolomide) in combination with the biological therapy (interferon-alpha-2a). Seven in vitro experiments were used in this study. The cytotoxicity of temozolomide, interferon-alpha-2a and the combination of them was measured on melanoma B16 cell line for 24 and 48 hours incubation periods. The cells of these lines were seeded in 96-well plate. Temozolomide was used in a six serial dilutions (6.25, 12.5, 25, 50, 100, 200) μg/ml. Interferon-alpha-2a was also used in a six serial dilutions (37500, 75000, 125000, 250000, 500000, 1000000) IU/ml. The MTT(3-(4,5-Dimethylthiazole-2-yl)-2,5-diphenyl- 2H-tetrazolium bromide) assay was used to determine the number of viable cells and the intensity of color was measured by ELISA reader. The combination of temozolomide and interferon-alpha-2a at 48 hours incubation period, there was a significant decrease (P≤ 0.05) in the viability percent of melanoma B16 cells for all concentrations of the combination therapy as compared to the control group

Lectures

2
View details